This announcement is a separate document:
株式会社ジャムコ：変更報告書（特例対象株券等）
Jamco Corp: Change report (special target stock, etc.)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
06:13
Financial institutions further standardize pricing behavior.
06:12
Securities Times: M1 'enrolling new members' keeping pace with the times, speeding up the reform of the monetary policy framework.
06:10
According to the announcement from Laika Pharmaceutical on the Hong Kong Stock Exchange, all subjects in the Phase I single-ascending-dose study (SAD study) for the treatment of obesity with LAE102 have completed the administration.
LAEKNA-B-2.67%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.